方法对比

	积极与消极情感量表 (PANAS)	抑郁焦虑压力量表-21 (DASS-21)	医院焦虑抑郁量表 (HADS)
领域	临床心理学	临床心理学	临床心理学
方法族	Process / pipeline	Process / pipeline	Process / pipeline
起源年份	1988	1995	1983
提出者	David Watson, Lee Anna Clark, and Auke Tellegen	Stephen H. Lovibond and Peter F. Lovibond	Andrew S. Zigmond and Richard P. Snaith
类型	Mood and affect self-assessment	Three-dimensional mental health screening	Anxiety and depression screening in medical populations
开创性文献	Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology, 54(6), 1063-1070.	Lovibond, S. H., & Lovibond, P. F. (1995). Manual for the Depression Anxiety Stress Scales. Psychology Foundation of Australia.	Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67(6), 361-370.
别名	PANAS, PANAS-X	DASS-21, DASS, DASS-42	HADS, HADS-A, HADS-D
相关	5	5	4
摘要	The Positive and Negative Affect Schedule (PANAS) is a brief, efficient self-report measure of mood and emotional affect. Developed by Watson, Clark, and Tellegen in 1988, it assesses two independent dimensions: positive affect (enthusiasm, attentiveness, interest) and negative affect (distress, anxiety, anger). The 20-item standard version is one of the most widely used instruments for measuring emotion in research and clinical contexts.	The Depression Anxiety Stress Scales-21 (DASS-21) is a 21-item self-report instrument measuring three correlated but distinct dimensions of psychological distress: depression, anxiety, and stress. Developed by Lovibond and Lovibond in 1995, the DASS-21 is a short form of the original 42-item DASS. It has become widely used in research and clinical settings for its brevity, multidimensional structure, and strong psychometric properties.	The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report instrument measuring anxiety and depression symptoms in medically ill populations. Developed by Zigmond and Snaith in 1983, the HADS was specifically designed for hospital and general medical settings where somatic symptoms of medical illness may confound assessment. It remains the standard anxiety-depression measure in medical, oncology, and cardiac populations worldwide.